Zacks Investment Research upgraded shares of Phibro Animal Health (NASDAQ:PAHC) from a sell rating to a hold rating in a research report report published on Monday morning.
According to Zacks, “Phibro ended second-quarter fiscal 2018 on a mixed note, with bottom line exceeding the Zacks Consensus Estimate and revenues declining marginally on a year-over-year basis. Segment-wise, a persistent decline in Mineral Nutrition segment sales is likely to prove a drag. Customer consolidation can also adversely affect Phibro’s revenues. Moreover, headwinds such as unfavorable currency movement and tough competitive scenario continue to pose threats. Over the past three months, Phibro has been trading below the broader industry. However, on a positive note, Animal Health remained the key contributing business, delivering positive growth on a year-over-year basis. We are also encouraged by the expansion in the gross margin in the reported quarter.”
Other equities research analysts also recently issued research reports about the company. BidaskClub raised Phibro Animal Health from a strong sell rating to a sell rating in a report on Saturday, January 6th. Piper Jaffray Companies reaffirmed a buy rating and issued a $42.00 target price on shares of Phibro Animal Health in a report on Friday, November 10th. Finally, ValuEngine downgraded Phibro Animal Health from a buy rating to a hold rating in a report on Thursday, November 9th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the stock. Phibro Animal Health currently has a consensus rating of Hold and an average target price of $38.25.
Phibro Animal Health (NASDAQ:PAHC) last issued its earnings results on Monday, November 6th. The company reported $0.38 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.37 by $0.01. The firm had revenue of $193.40 million for the quarter, compared to the consensus estimate of $189.89 million. Phibro Animal Health had a return on equity of 39.76% and a net margin of 8.22%. The company’s revenue was up 2.9% compared to the same quarter last year. During the same quarter last year, the business posted $0.36 EPS. analysts expect that Phibro Animal Health will post 1.57 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Wednesday, December 27th. Stockholders of record on Wednesday, December 6th were paid a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.12%. The ex-dividend date was Tuesday, December 5th. Phibro Animal Health’s payout ratio is 23.53%.
Several institutional investors and hedge funds have recently made changes to their positions in the company. Copper Rock Capital Partners LLC lifted its stake in shares of Phibro Animal Health by 9.6% in the 4th quarter. Copper Rock Capital Partners LLC now owns 631,876 shares of the company’s stock valued at $21,326,000 after acquiring an additional 55,235 shares during the last quarter. Algert Global LLC raised its position in Phibro Animal Health by 18.8% during the 3rd quarter. Algert Global LLC now owns 79,802 shares of the company’s stock worth $2,957,000 after purchasing an additional 12,647 shares during the last quarter. California Public Employees Retirement System raised its position in Phibro Animal Health by 9.5% during the 3rd quarter. California Public Employees Retirement System now owns 44,994 shares of the company’s stock worth $1,667,000 after purchasing an additional 3,894 shares during the last quarter. U S Global Investors Inc. bought a new position in Phibro Animal Health during the 3rd quarter worth $1,071,000. Finally, Cornerstone Capital Management Holdings LLC. raised its position in Phibro Animal Health by 7.5% during the 3rd quarter. Cornerstone Capital Management Holdings LLC. now owns 127,421 shares of the company’s stock worth $4,720,000 after purchasing an additional 8,900 shares during the last quarter. Institutional investors own 48.42% of the company’s stock.
Phibro Animal Health Company Profile
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.